Zoftariz 1gm Injection
Marketer
Elder Pharmaceuticals Ltd
Salt Composition
Ceftriaxone (1gm)
Overview Zoftariz 1gm Injection
Ceftolozane/tazobactam 1g injection, a cephalosporin antibiotic, combats various bacterial infections. Its applications encompass infections affecting the brain (meningitis), lungs (pneumonia), ears, urinary tract, skin and soft tissues, bones and joints, blood, and heart. Prophylactic use during surgery is also indicated. Administered intravenously (IV drip) or via intramuscular injection by a healthcare professional, the dosage is determined by your physician. Consistent, evenly spaced doses, as prescribed, are crucial. Complete the entire course, even with symptom improvement, to prevent relapse. Premature cessation may result in infection recurrence or exacerbation. Common adverse effects include diarrhea, rash, altered liver function test results, and variations in blood cell counts (e.g., eosinophilia, leukopenia, thrombocytopenia). Localized injection site redness or pain may occur temporarily. While usually mild, report persistent or bothersome effects to your doctor. Prior to treatment, disclose any antibiotic allergies, kidney or liver impairments, and all other medications you are using, as interactions are possible.
Uses of Zoftariz 1gm Injection
Combating bacterial infections
Major Benefits of Zoftariz 1gm Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Zoftariz 1gm Injection:
- Diarrhea
- Abnormal liver function tests
- Rash
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count
- Low blood platelets
How to use Zoftariz 1gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Zoftariz 1gm Injection works:
Zoftariz 1g injection is a bactericidal antibiotic. Its mechanism of action involves disrupting bacterial cell wall synthesis, thereby eliminating the bacteria's protective barrier and leading to its demise.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Zoftariz 1gm Injection and alcohol.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Zoftariz 1gm Injection is considered safe. Research predominantly indicates minimal or absent risk to the fetus.
Breast feedingCAUTION
Administering Zoftariz 1gm Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administration of Zoftariz 1gm Injection may cause drowsiness, visual disturbances, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
The intravenous administration of Zoftariz 1gm is considered safe for individuals with impaired renal function. No alteration of the Zoftariz 1gm dosage is necessary. Nevertheless, disclosure of pre-existing kidney conditions to your physician is advised.
LiverCAUTION
The administration of Zoftariz 1gm Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Zoftariz 1gm Injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Zoftariz 1gm Injection :
Should you forget a scheduled dose of Zoftariz 1gm Injection, seek advice from your physician.
Facts to Know About Zoftariz 1gm Injection
| Label | Value |
|---|---|
| Chemical Type | Extended-Spectrum Cephalosporins (Generations 3 & 4) |
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
3,018 People bought this recently